The Qid® is the world’s first FDA approved transponder for use in humans. It was FDA cleared in 2004 and the only one with CE-Mark for use in a breast implant. It consists of a biocompatible RFID (passive radio-frequency identification) microtransponder which provides an electronic serial number that is accessed by an owned handheld reader (Motiva Q Inside® Reader Standard) when waved over the breast area for traceability post-implantation. Motiva Implants® are available with and without a microtransponder. The microtransponder is a device which is placed in the breast implant filler material. It has been separately reviewed and cleared for marketing by the FDA for use as an implantable microchip that is inserted into the subcutaneous tissue of a patient to provide an electronic serial number that may be used to access a database containing the patient’s identity and health information.